Guggenheim sees big upside for Tetraphase

|About: Tetraphase Pharmaceuticals (TTPH)|By:, SA News Editor

Tetraphase Pharmaceuticals (TTPH +5.3%)  is trading notably higher on the session.

Likely helping the cause is Guggenheim, where analysts initiated the shares at Buy.

Price target is $25, representing upside of around 144% from Tuesday's close.